This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is important while injecting the PPD to administer the Mantoux test? a. ... (Read 8 times)

abc

  • Hero Member
  • *****
  • Posts: 543
Which of the following is important while injecting the PPD to administer the Mantoux test?
 a. Locate a site approximately 68 inches from the antecubital space.
  b. Administer the injection subcutaneously.
  c. Inject 0.2 ml of PPD.
  d. Make sure a wheal forms at the injection site.

Question 2

Which grasp is used when using the HVE for the anterior?
 a. Modified pen
  b. Pen
  c. Thumb-to-nose
  d. Either a or b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jaykayy05

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

d

Answer to Question 2

d
RATIONALE: The grasp used when using the HVE for the anterior is the modified pen or pen grasp.




abc

  • Member
  • Posts: 543
Reply 2 on: Jun 25, 2018
Wow, this really help


juliaf

  • Member
  • Posts: 344
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

For a complete list of videos, visit our video library